DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Tipepidine

Tipepidine

  • Using the Drug Repositioning Approach to Develop A

    Using the Drug Repositioning Approach to Develop A

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • General Pharmacology

    General Pharmacology

  • Treatment of Attention Deficit Hyperactivity Disorder: New Agents and Assessment Tools Marcia L

    Treatment of Attention Deficit Hyperactivity Disorder: New Agents and Assessment Tools Marcia L

  • Jp Xvii the Japanese Pharmacopoeia

    Jp Xvii the Japanese Pharmacopoeia

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

    Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

  • Biol. Pharm. Bull. 39(5): 856-862 (2016)

    Biol. Pharm. Bull. 39(5): 856-862 (2016)

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Pharmaceuticals and Medical Devices Safety Information No

    Pharmaceuticals and Medical Devices Safety Information No

  • Potassium Channel Kcsa

    Potassium Channel Kcsa

  • Medicines Amendment Regulations 2018

    Medicines Amendment Regulations 2018

  • Multiple Pharmacological Actions of Centrally Acting Antitussives — Do They Target G Protein-Coupled Inwardly Rectifying K+ (GIRK) Channels?

    Multiple Pharmacological Actions of Centrally Acting Antitussives — Do They Target G Protein-Coupled Inwardly Rectifying K+ (GIRK) Channels?

  • Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition

    Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition

  • Using the Drug Repositioning Approach to Develop a Novel Therapy

    Using the Drug Repositioning Approach to Develop a Novel Therapy

  • Suspending Syrups Suspendierfahige Sirupe Sirops Ayant Des Proprietes De Mise En Suspension

    Suspending Syrups Suspendierfahige Sirupe Sirops Ayant Des Proprietes De Mise En Suspension

  • Suspending Syrups

    Suspending Syrups

  • The Seventeenth Edition of the Japanese Pharmacopoeia (JP17) Was Partially Revised As Follows

    The Seventeenth Edition of the Japanese Pharmacopoeia (JP17) Was Partially Revised As Follows

Top View
  • Poisons Standard February 2020
  • Articles a Giraffe and a Half Poem a Giraffe and a Half Poem
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Marrakesh Agreement Establishing the World Trade Organization
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • General Information
  • Pharmaabkommen A1 E
  • Tipepidine in Children with Attention Deficit/ Hyperactivity Disorder: a 4-Week, Open-Label, Preliminary Study
  • (12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
  • Australian Statistics on Medicines 2009
  • 熊本大学学術リポジトリ Kumamoto University Repository System
  • Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
  • Alcohol Modulation of G-Protein-Gated Inwardly Rectifying Potassium Channels: from Binding to Therapeutics
  • POISONS LIST APPENDIX Amoebicides
  • Literature Search Strategy for Treatment of Stable
  • 800155000 22300Amx00422 K
  • Customs Tariff - Schedule Xxi - 1
  • Drug Repurposing Compound Library Plus (96-Well)


© 2024 Docslib.org    Feedback